Data

The Moo'D Study: A randomised controlled trial of A2 vs conventional dairy products in women with low mood.

Health Data Australia Contributor Records
Jacka, Felice ; Mental Health Node
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.26187/B0HQ-Z006&rft.title=The Moo'D Study: A randomised controlled trial of A2 vs conventional dairy products in women with low mood.&rft.identifier=http://doi.org/10.26187/B0HQ-Z006&rft.publisher=Deakin University&rft.description=This trial evaluated the comparative effects of consumption of dairy products containing A2 beta-casein versus conventional dairy (i.e. containing both A1 and A2 beta-casein) on symptoms of psychological distress in women with low mood. ‘The Moo’D Study’ is a 16-week, superiority, 1:1 parallel group, triple-blinded, randomised controlled trial. Ninety women with low mood (Patient Health Questionnaire score ≥ 5) will be randomised to consume either A2 beta-casein only or conventional dairy products. The primary outcome, symptoms of psychological distress, were measured by the 21-item Depression, Anxiety and Stress Scale. Secondary outcomes include symptoms of depression, anxiety and stress, severity of low mood, cognition, gut microbiota composition, gut symptomatology, markers of immune function, gut inflammation, systemic metabolites, endothelial integrity and oxidative stress, body composition, perceived wellbeing, sleep, quality of life, resource use and cost-effectiveness.&rft.creator=Jacka, Felice &rft.creator=Mental Health Node &rft.date=2021&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12618002023235&rft.type=dataset&rft.language=English Access the data

Full description

This trial evaluated the comparative effects of consumption of dairy products containing A2 beta-casein versus conventional dairy (i.e. containing both A1 and A2 beta-casein) on symptoms of psychological distress in women with low mood. ‘The Moo’D Study’ is a 16-week, superiority, 1:1 parallel group, triple-blinded, randomised controlled trial. Ninety women with low mood (Patient Health Questionnaire score ≥ 5) will be randomised to consume either A2 beta-casein only or conventional dairy products. The primary outcome, symptoms of psychological distress, were measured by the 21-item Depression, Anxiety and Stress Scale. Secondary outcomes include symptoms of depression, anxiety and stress, severity of low mood, cognition, gut microbiota composition, gut symptomatology, markers of immune function, gut inflammation, systemic metabolites, endothelial integrity and oxidative stress, body composition, perceived wellbeing, sleep, quality of life, resource use and cost-effectiveness.

Notes

HeSANDA 1.0.0

This dataset is part of a larger collection

Click to explore relationships graph

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers